J. Gardette

He has founded 10+ companies in his career,  with successful exits: 6 of these being sold to large lifescience companies such as Bard, Baxter or Nipro Healthcare in various areas from Dialysis, Drug Delivery Devices or Cardiac Valves.

Former funder and principal shareholder of Biocorp, now sold to Novo Nordisk for 154M€

Pioneer in innovative medicale devices,  and currently listed on Alternext Paris.